Skip to main content
The Globe and Mail
Get full access to globeandmail.com
Support quality journalism
Just $1.99 per week for the first 24weeks
Just $1.99 per week for the first 24weeks
Start today
Start Today
The Globe and Mail
Support quality journalism
Get full access to globeandmail.com
Globe and Mail website displayed on various devices
Just$1.99
per week
for the first 24weeks

Start today
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){console.log("scroll");var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))}pencilInit(".js-sub-pencil",!1);

Canopy Growth Corp (WEED-T) Quote

Register
AdChoices
TSX Real-Time Last Sale CAD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 19.15
Day High 20.46
Open:19.72
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Latest
cannabis
Canopy Growth closing Tokyo Smoke and Tweed retail stores
inside the market
Wednesday’s small-cap stocks to watch
Subscriber content
investment ideas
Cannabis ETFs inch higher after touching all-time lows
inside the market
Market movers: Stocks that saw action on Thursday - and why
Subscriber content
inside the market
What every Canadian investor needs to know today
Subscriber content
report on business
Canopy Growth to close two greenhouses, lay off 500 employees
Subscriber content
Description
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

View Earnings

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

View Estimates zacks

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Download Report (PDF) Thomson Reuters

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Download Report (PDF) StockCalc

ValuEngine Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Download Report (PDF) ValueEnfine

Latest Press Releases

More Stories
COVID-19 Killed North Dakota’s Marijuana Legalization Dreams
- Market Realist - Mon Apr 6, 10:05AM CDT
Market Realist - CMTX
Mon Apr 6, 10:05AM CDT
Right now, marijuana legalization in 2020 doesn't seem possible for many states due to the COVID-19 pandemic. Since the pandemic hit, states have taken numerous measures to impose social distancing. Currently, social distancing is the only effective way to contain the spread of the virus. Canceling large public events and gatherings has put a halt on signature gathering for legalization campaigns. Recently, Idaho suspended its marijuana legalization campaign. The state wasn't able to collect enough signatures. North Dakota might be the next state to cancel its marijuana legalization initiative.
Canopy Growth’s Vaporizer Device Gets Health Canada Approval
- Market Realist - Mon Apr 6, 9:33AM CDT
Market Realist - CMTX
Mon Apr 6, 9:33AM CDT
On April 3, Canopy Growth (NYSE:CGC)(TSE:WEED) for Volcano Medic 2--its vaporizing device. Storz & Bickel, a subsidiary of Canopy Growth, developed the product. Canopy Growth acquired the German vaporizer design and manufacturer in December 2018 for approximately 145 million euros. The medical device license allows device distribution to patients, clinics, and medical institutions in Canada. Also, the license allows the distribution through Spectrum Therapeutics--Canopy Growth's medical cannabis division. Earlier, Europe and Australia approved the device for medical use.
What Can You Expect from Marijuana Stocks in April?
- Market Realist - Mon Apr 6, 8:12AM CDT
Market Realist - CMTX
Mon Apr 6, 8:12AM CDT
Marijuana stocks were on a rollercoaster ride in March. After struggling in 2019, the marijuana sector didn't start 2020 on a good note either. The Horizons Marijuana Life Sciences ETF (TSE:HMMJ) tracks the North American cannabis industry. HMMJ fell by 18.8% in March. Overall, the month didn't start off well for the cannabis sector even before the coronavirus pandemic hit. Surprisingly, while COVID-19 has impacted other sectors, it has helped the cannabis sector. The demand for cannabis increased and sales rose. Cannabis stocks' performance also improved. Let's take a look at how cannabis stocks performed in March. What can investors expect from marijuana stocks in April?
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 12.96 +56.33% increase
on 03/16/20
Period Open:20.47
Price movement based on the high, low and last over the given period.
22.98 -11.84% decrease
on 03/26/20
 -0.21 (-1.03%) decrease
since 03/06/20
3-Month 12.96 +56.33% increase
on 03/16/20
Period Open:26.02
Price movement based on the high, low and last over the given period.
33.86 -40.17% decrease
on 01/15/20
 -5.76 (-22.14%) decrease
since 01/06/20
52-Week 12.96 +56.33% increase
on 03/16/20
Period Open:58.00
Price movement based on the high, low and last over the given period.
70.98 -71.46% decrease
on 04/30/19
 -37.74 (-65.07%) decrease
since 04/05/19

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2020.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies